A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)

Journal of Steroid Biochemistry and Molecular Biology

Volumn 143, Issue , 2014, Pages 404-415

  Africander, Donita J ^a   Storbeck, Karl Heinz ^a   Hapgood, Janet P ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Androgen receptor; Binding; Injectable contraceptives; N C interaction; Progestins; Transcription

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; NORETHISTERONE ACETATE; PROGESTERONE; ANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; AR PROTEIN, HUMAN; LUCIFERASE; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; CONTROLLED STUDY; COS 1 CELL LINE; DNA RESPONSIVE ELEMENT; DRUG MECHANISM; DRUG STRUCTURE; EXPERIMENTAL MONKEY; HORMONAL THERAPY; MOLECULAR DOCKING; NONHUMAN; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TRANSCRIPTION INITIATION; ANALOGS AND DERIVATIVES; ANIMAL; CHLOROCEBUS AETHIOPS; HUMAN; METABOLISM; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ANDROGENS; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CONTRACEPTIVES, ORAL, SYNTHETIC; COS CELLS; HUMANS; LUCIFERASES; MEDROXYPROGESTERONE ACETATE; NORETHINDRONE; PROGESTERONE; PROGESTINS; RECEPTORS, ANDROGEN; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84903162119     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.05.007     Document Type: Article

References (78)

1. C.A. Blish, and J.M. Beaten Hormonal contraception and HIV-1 transmission Am. J. Reprod. Immunol. 65 3 2011 302 307
2. C.S. Morrison, S. Skoler-Karpoff, C. Kwok, P.L. Chen, J. van de Wijgert, M. Gehret-Plagianos, S. Patel, K. Ahmed, G. Ramjee, B. Friedland, and P. Lahteenmaki Hormonal contraception and the risk of HIV acquisition among women in South Africa AIDS 26 2012 497 504
3. F.Z. Stanczyk, and S. Roy Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids Contraception 42 1 1990 67 96 (Pubitemid 20208813)
4. J.E. Rossouw, G.L. Anderson, R.L. Prentice, A.Z. LaCroix, C. Kooperberg, M.L. Stefanick, R.D. Jackson, S.A.A. Beresford, B.V. Howard, K.C. Johnson, J.M. Kotchen, and J. Ockene Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 3 2002 321 333 (Pubitemid 34761611)
5. V. Beral, E. Banks, D. Bull, and G. Reeves Breast cancer and hormone-replacement therapy in the Million Women Study Lancet 362 2003 419 427 (Pubitemid 36999703)
6. F.Z. Stanczyk, J.P. Hapgood, S. Winer, and D.R. Mishell Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects Endocr. Rev. 34 2 2013
7. J.P. Hapgood, D. Koubovec, A. Louw, and D. Africander Not all progestins are the same: implications for usage Trends Pharmacol. Sci. 25 11 2004 554 557 (Pubitemid 39371144)
8. D. Africander, N. Verhoog, and J.P. Hapgood Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception Steroids 76 2011 636 652
9. C. Bamberger, T. Else, A.-M. Bamberger, F. Beil, and H. Schulte Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes J. Clin. Endocrinol. Metab. 84 1999 4055 4061 (Pubitemid 30644194)
10. D. Koubovec, W. Vanden Berghe, L. Vermeulen, G. Haegeman, and J.P. Hapgood Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells Mol. Cell. Endocrinol. 221 2004 75 83
11. T. Ouatas, D. Halverson, and P.S. Steeg Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds Clin. Cancer Res. 9 10 Pt 1 2003 3763 3772 (Pubitemid 37169246)
12. D. Koubovec, K. Ronacher, E. Stubsrud, A. Louw, and J.P. Hapgood Synthetic progestins used in HRT have different glucocorticoid agonist properties Mol. Cell. Endocrinol. 242 1-2 2005 23 32 (Pubitemid 41393707)
13. F.A. Teulings, H.A. van Gilse, M.S. Henkelman, H. Portengen, and J. Alexieva-Figusch Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer Cancer Res. 40 7 1980 2557 2561 (Pubitemid 10082284)
14. G. Perez-Palacios, B. Chavez, F. Vilchis, N. Escobar, F. Larrea, and A.E. Perez Interaction of medroxyprogesterone acetate with cytosol androgen receptors in the rat hypothalamus and pituitary J. Steroid Biochem. 19 6 1983 1729 1735
15. E.W. Bergink, F. van Meel, E.W. Turpijn, and J. van der Vies Binding of progestagens to receptor proteins in MCF-7 cells J. Steroid Biochem. 19 5 1983 1563 1570 (Pubitemid 14205827)
16. R. Hackenberg, T. Hawighorst, A. Filmer, A.H. Nia, and K.D. Schulz Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor Breast Cancer Res. Treat. 25 3 1993 217 224 (Pubitemid 23198726)
17. J.M. Bentel, S.N. Birrell, M.A. Pickering, D.J. Holds, D.J. Horsfall, and W.D. Tilley Androgen receptor agonist activity of the synthetic progestin, medroxyprogesterone acetate, in human breast cancer cells Mol. Cell. Endocrinol. 154 1999 11 20 (Pubitemid 29387325)
18. J.A. Kemppainen, E. Langley, C.I. Wong, K. Bobseine, W.R. Kelce, and E.M. Wilson Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone Mol. Endocrinol. 13 3 1999 440 454 (Pubitemid 29113876)
19. W.G. Schoonen, G.H. Deckers, M.E. de Gooijer, R. de Ries, and H.J. Kloosterboer Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives J. Steroid Biochem. Mol. Biol. 74 4 2000 213 222 (Pubitemid 32121657)
20. G.H. Deckers, W.G. Schoonen, and H.J. Kloosterboer Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals J. Steroid Biochem. Mol. Biol. 74 3 2000 83 92
21. D. Africander, R. Louw, and J.P. Hapgood Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy Biochem. Biophys. Res. Commun. 433 2013 305 310
22. A.E. Schindler, C. Campagnoli, R. Druckmann, J. Huber, J.R. Pasqualini, K.W. Schweppe, and J.H. Thijssen Classification and pharmacology of progestins Maturitas 46 Suppl. 1 2003 S7 S16
23. H. Kuhl Pharmacology of progestens J. Reproduktionsmed. Endokrinol. 8 Special Issue 1 2011 157 176
24. R. Ghatge, B. Jacobsen, S. Schittone, and K. Horwitz The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells Breast Cancer Res. 7 6 2005 R1036 R1050
25. D. Africander, R. Louw, N. Verhoog, D. Noeth, and J.P. Hapgood Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract Contraception 84 4 2011 423 435
26. A.M. Ochnik, N.L. Moore, T. Jankovic-Karasoulos, T. Bianco-Miotto, N.K. Ryan, M.R. Thomas, S.N. Birrell, L.M. Butler, W.D. Tilley, and T.E. Hickey Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo Menopause 21 1 2014 79 88
27. C.M. Wilson, and M.J. McPhaul A and B forms of the androgen receptor are expressed in a variety of human tissues Mol. Cell. Endocrinol. 120 1 1996 51 57 (Pubitemid 26197261)
28. R. Evans The steroid and thyroid hormone receptor superfamily Science 240 4854 1988 889 895
29. M. Beato Gene regulation by steroid hormones Cell 56 3 1989 335 344 (Pubitemid 19052651)
30. B. He, J.A. Kemppainen, J.J. Voegel, H. Gronemeyer, and E.M. Wilson Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain J. Biol. Chem. 274 52 1999 37219 37225
31. B. He, J.A. Kemppainen, and E.M. Wilson FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor J. Biol. Chem. 275 30 2000 22986 22994 (Pubitemid 30646187)
32. B. He, J.T. Minges, L.W. Lee, and E.M. Wilson The FXXLF motif mediates androgen receptor-specific interactions with coregulators J. Biol. Chem. 277 12 2002 10226 10235 (Pubitemid 34968137)
33. E. Langley, Z.X. Zhou, and E.M. Wilson Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer J. Biol. Chem. 270 50 1995 29983 29990 (Pubitemid 26001674)
34. P.E. Lonergan, and D.J. Tindall Androgen receptor signaling in prostate cancer development and progression J. Carcinog. 10 2011 20
35. F. Schaufele, X. Carbonell, M. Guerbadot, S. Borngraeber, M.S. Chapman, A.A. Ma, J.N. Miner, and M.I. Diamond The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions Proc. Natl. Acad. Sci. U. S. A. 102 28 2005 9802 9807 (Pubitemid 40993649)
36. J. Jaaskelainen, A. Deeb, J.W. Schwabe, N.P. Mongan, H. Martin, and I.A. Hughes Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains J. Mol. Endocrinol. 36 2 2006 361 368
37. S.A. Ghali, B. Gottlieb, R. Lumbroso, L.K. Beitel, Y. Elhaji, J. Wu, L. Pinsky, and M.A. Trifiro The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity J. Clin. Endocrinol. Metab. 88 5 2003 2185 2193 (Pubitemid 36549896)
38. J.A. Kemppainen, M.V. Lane, M. Sar, and E.M. Wilson Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones J. Biol. Chem. 267 1992 968 974
39. L.N. Song, M. Coghlan, and E.P. Gelmann Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptor Mol. Endocrinol. 18 1 2004 70 85 (Pubitemid 38073155)
40. X. Sui, K.S. Bramlett, M.C. Jorge, D.A. Swanson, A.C. von Eschenbach, and G. Jenster Specific androgen receptor activation by an artificial coactivator J. Biol. Chem. 274 14 1999 9449 9454
41. A.O. Brinkmann, P.W. Faber, H.C.J. van Rooij, G.G.J.M. Kuiper, C. Ris, P. Klaassen, J.A.G.M. van der Korput, M.M. Voorhorst, J.H. van Laar, E. Mulder, and J. Trapman The human androgen receptor: domain structure, genomic organization and regulation of expression J. Steroid Biochem. 34 1-6 1989 307 310 (Pubitemid 20061799)
42. P. Alen, F. Claessens, G. Verhoeven, W. Rombauts, and B. Peeters The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription Mol. Cell. Biol. 19 9 1999 6085 6097 (Pubitemid 29399314)
43. K. Schauwaers, K. De Gendt, P.T.K. Saunders, N. Atanassova, A. Haelens, L. Callewaert, U. Moehren, J.V. Swinnen, G. Verhoeven, G. Verrijdt, and F. Claessens Loss of androgen receptor binding to selective androgen response elements causes a reproductive phenotype in a knockin mouse model Proc. Natl. Acad. Sci. U.S.A. 104 12 2007 4961 4966 (Pubitemid 47186159)
44. R.I. Freshney Culture of Animal Cells. A Manual of Basic Technique fourth ed. 1987 Wiley-Liss New York
45. C.M. Bamberger, A.-M. Bamberger, M. de Castro, and G.P. Chrousos Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans J. Clin. Invest. 95 1995 2435 2441
46. Y. Cheng, and W.H. Prusoff Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22 23 1973 3099 3108
47. Y. Luo, A. Batalao, H. Zhou, and L. Zhu Mammalian two-hybrid system: a complementary approach to the yeast two-hybrid system Biotechniques 22 2 1997 350 352 (Pubitemid 27083752)
48. A.S. Konagurthu, J.C. Whisstock, P.J. Stuckey, and A.M. Lesk MUSTANG: a multiple structural alignment algorithm Proteins 64 3 2006 559 574 (Pubitemid 44100724)
49. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, and A.J. Olson Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function J. Comput. Chem. 19 1998 1639 1662 (Pubitemid 128590223)
50. U. Fuhrmann, R. Krattenmacher, E.P. Slater, and K.-H. RFritzemeier The novel progestin Drospirenone and its natural counterpart Progesterone: biochemical profile and antiandrogenic potential Contraception 54 1996 243 251 (Pubitemid 26398621)
51. P. Doesburg, C.W. Kuil, C.A. Berrevoets, K. Steketee, P.W. Faber, E. Mulder, A.O. Brinkmann, and J. Trapman Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor Biochemistry 36 5 1997 1052 1064 (Pubitemid 27076365)
52. S.N. Birrell, L.M. Butler, J.M. Harris, G. Buchanan, and W.D. Tilley Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer FASEB J. 21 10 2007 2285 2293 (Pubitemid 47230658)
53. K.P. de Jesus-Tran, P.L. Cote, L. Cantin, J. Blanchet, F. Labrie, and R. Breton Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity Protein Sci. 15 5 2006 987 999
54. X.E. Zhou, K.M. Suino-Powell, J. Li, Y. He, J.P. Mackeigan, K. Melcher, E.L. Yong, and H.E. Xu Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor J. Biol. Chem. 285 12 2010 9161 9171
55. B. He, R.T. Gampe Jr., A.J. Kole, A.T. Hnat, T.B. Stanley, G. An, E.L. Stewart, R.I. Kalman, J.T. Minges, and E.M. Wilson Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance Mol. Cell 16 3 2004 425 438 (Pubitemid 39504796)
56. A.K. Death, K.C. McGrath, R. Kazlauskas, and D.J. Handelsman Tetrahydrogestrinone is a potent androgen and progestin J. Clin. Endocrinol. Metab. 89 5 2004 2498 2500 (Pubitemid 38619895)
57. R. Kumar, and I.J. McEwan Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation Endocr. Rev. 33 2 2012 271 299
58. E.B. Askew, J.T. Minges, A.T. Hnat, and E.M. Wilson Structural features discriminate androgen receptor N/C terminal and coactivator interactions Mol. Cell. Endocrinol. 348 2 2012 403 410
59. H. Singh, J.P. Uniyal, P. Jha, K. Murugesan, D. Takkar, V. Hingorani, and K.R. Laumas Pharmacokinetics of norethindrone acetate in women Am. J. Obstet. Gynecol. 135 1979 409 414 (Pubitemid 9253650)
60. F.Z. Stanczyk Structure-function relationships, pharmacokinetics, and potency or orally and parentally administered progestogens intervention R.A. Lobo, Treatment of the Postmenopausal Woman: Basic and Clinical Aspects 3rd ed. 2007 Academic Press Burlington, MA
61. X.Y. Zhao, D.M. Peehl, N.M. Navone, and D. Feldman 1alpha,25- Dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms Endocrinology 141 7 2000 2548 2556 (Pubitemid 32269075)
62. S. Sasagawa, Y. Shimizu, H. Kami, T. Takeuchi, S. Mita, K. Imada, S. Kato, and K. Mizuguchi Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile Steroids 73 2 2008 222 231
63. J.J. Palvimo, P. Reinikainen, T. Ikonen, P.J. Kallio, A. Moilanen, and O.A. Janne Mutual transcriptional interference between RelA and androgen receptor J. Biol. Chem. 271 39 1996 24151 24156 (Pubitemid 26327398)
64. T. Bellido, R.L. Jilka, B.F. Boyce, G. Girasole, H. Broxmeyer, S.A. Dalrymple, R. Murray, and S.C. Manolagas Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor J. Clin. Invest. 95 6 1995 2886 2895
65. K. Ronacher, K. Hadley, C. Avenant, E. Stubsrud, S.S. Simons, A. Louw, and J.P. Hapgood Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction Mol. Cell. Endocrinol. 299 2009 219 231
66. T.M. Tanner An investigation of the interactions of the androgen receptor with a non-steroidal compound and two synthetic progestins PhD thesis 2002 Department of Biochemistry University of Stellenbosch Stellenbosch
67. D.J. Tindall, and J. Mohler Androgen Action in Prostate Cancer 2009 Springer Science and Business Media, LLC
68. S.H. Meijsing, M.A. Pufall, A.Y. So, D.L. Bates, L. Chen, and K.R. Yamamoto DNA binding site sequence directs glucocorticoid receptor structure and activity Science 324 5925 2009 407 410
69. C. Helsen, V. Dubois, A. Verfaillie, J. Young, M. Trekels, R. Vancraenenbroeck, M. De Maeyer, and F. Claessens Evidence for DNA-binding domain-ligand-binding domain communications in the androgen receptor Mol. Cell. Biol. 32 15 2012 3033 3043
70. H.C. Shen, G. Buchanan, L.M. Butler, J. Prescott, M. Henderson, W.D. Tilley, and G.A. Coetzee GRIP1 mediates the interaction between the amino- and carboxyl-termini of the androgen receptor Biol. Chem. 386 1 2005 69 74 (Pubitemid 40361453)
71. J. Li, J. Fu, C. Toumazou, H.G. Yoon, and J. Wong A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin Mol. Endocrinol. 20 4 2006 776 785
72. F. Larrea, R. Garcia-Becerra, A.E. Lemus, G.A. Garcia, G. Perez-Palacios, K.J. Jackson, K.M. Coleman, R. Dace, C.L. Smith, and A.J. Cooney A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha Endocrinology 142 9 2001 3791 3799 (Pubitemid 32807699)
73. M.E. de Gooyer, G.H. Deckers, W.G. Schoonen, H.A. Verheul, and H.J. Kloosterboer Receptor profiling and endocrine interactions of tibolone Steroids 68 1 2003 21 30 (Pubitemid 35422732)
74. H.J. Kloosterboer Tissue-selectivity: the mechanism of action of tibolone Maturitas 48 Suppl. 1 2004 S30 S40
75. J.F. Dunn, B.C. Nisula, and D. Rodbard Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma J. Clin. Endocrinol. Metab. 53 1 1981 58 68 (Pubitemid 13245381)
76. K. Shrimanker, B.N. Saxena, and K. Fotherby A radioimmunoassay for serum medroxyprogesterone acetate J. Steroid Biochem. 9 4 1978 359 363 (Pubitemid 8349058)
77. K.T. Kirton, and J.C. Cornette Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera) Contraception 10 1 1974 39 45
78. K. Fotherby Variability of pharmacokinetic parameters for contraceptive steroids J. Steroid Biochem. 19 1C 1983 817 820